Comparing two doses of Chloroprocaine for effective spinal Anaesthesia in patients receiving brachytherapy for carcinoma cervix
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: N879- Dysplasia of cervix uteri, unspecifiedHealth Condition 2: C539- Malignant neoplasm of cervix uteri, unspecifiedHealth Condition 3: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2019/06/019567
- Lead Sponsor
- n sneha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients belonging to ASA 1 and 2
patients consenting for study
patients undergoing brachytherapy
Exclusion Criteria
patients belonging to ASA 3 and 4
patients who are contraindicated for spinal anaesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method onset of sensory blockade <br/ ><br>duration of motor blockade <br/ ><br>peak block heightTimepoint: every 3 minutes for first 15 min minutes,every 15 minutes for 1 hour, then every hour for next 24 hours
- Secondary Outcome Measures
Name Time Method Hemodynamics <br/ ><br>Timepoint: 24 hours